Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05596240 · ClinicalTrials.gov registry record · NA
Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain
A NA study of Shoulder Pain and Dry Needling, sponsored by Texas Woman's University.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05596240 is a NA study of Shoulder Pain and Dry Needling that is active but no longer recruiting, run by Texas Woman's University. The registered enrollment target is 40 participants, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05596240, a NA study of Shoulder Pain and Dry Needling, is active but no longer recruiting, sponsored by Texas Woman's University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Shoulder pain is one of the most common reasons people consult with their primary health care provider, and 40-50% of these patients with shoulder pain continued to complain of persistent symptoms after 6 to 12 months. It has been suggested that the presence of myofascial trigger points (MTrPs) may contribute to the chronicity of shoulder symptoms. An MTrP is a hyperirritable taut band of tissue within a muscle that produces pain when stimulated MTrPs are common in patients with shoulder disorders and occur most often in the infraspinatus muscle of a painful shoulder MTrPs were associated with an acidic biochemical environment with elevated levels of inflammatory mediators, neuropeptides, and proinflammatory cytokines such as bradykinin and calcitonin g-related peptide. It was hypothesized that metabolic demands on muscle and capillary constrictions may contribute to the development of MTrPs. To date, only a few studies have examined the vascular environment of MTrPs and surrounding areas before and after dry needling. No studies have yet examined whether dry needling would change blood flow in patients with shoulder pathology. Therefore, the purpose of this pilot study is to examine the effect of dry needling on blood flow of the infraspinatus muscle using color Doppler imaging in individuals with shoulder pain. The secondary purpose is to examine the effect of DN on shoulder motion and sensitivity to pressure in individuals with shoulder pain.
Conditions Studied
Interventions
- OTHER Dry Needling
- OTHER Sham Dry Needling
Study Locations (1)
Texas
- Texas Woman's University T. Boone Pickens Institute of Health Sciences - Dallas Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-10-22 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05596240
The ClinicalTrials.gov registry entry for NCT05596240 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (60% lower). The listed sponsor is Texas Woman's University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which Dry Needling is the first listed.
NCT05596240 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05596240 about?
NCT05596240 is a clinical study titled "Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain". Shoulder pain is one of the most common reasons people consult with their primary health care provider, and 40-50% of these patients with shoulder pain continued to complain of persistent symptoms after 6 to 12 months. It has been suggested that the presence of myofascial trigger points (MTrPs) may ...
What is the current status of trial NCT05596240?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-10-22. Estimated completion is 2025-10-31.
What conditions does trial NCT05596240 study?
This clinical trial studies the following conditions: Shoulder Pain, Dry Needling.
What interventions are being tested in trial NCT05596240?
The interventions under investigation include: Dry Needling (OTHER), Sham Dry Needling (OTHER).
Who is sponsoring clinical trial NCT05596240?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05596240 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient Outcomes Collection: How Can we do Better?
RECRUITING · NA
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
-
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
RECRUITING · NA
-
BFRT for Subacromial Pain
RECRUITING · NA
-
How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Chiropractic Adjustive Technique
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.